3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
150
Stomach Neoplasms
52
Neoplasms
49
Pancreatic Neoplasms
41
Neoplasm Metastasis
32
Squamous Cell Carcinoma of Head and Neck
26
Head and Neck Neoplasms
25
Esophageal Neoplasms
24
Colonic Neoplasms
22
Rectal Neoplasms
21
Carcinoma, Non-Small-Cell Lung
21
Breast Neoplasms
20
Parkinson Disease 4, Autosomal Dominant Lewy Body
19
Esophageal Squamous Cell Carcinoma
15
Adenocarcinoma
14
Adenocarcinoma Of Esophagus
12
Cholangiocarcinoma
11
Biliary Tract Neoplasms
11
Ovarian Neoplasms
9
Triple Negative Breast Neoplasms
7
Gallbladder Neoplasms
7
Carcinoma, Hepatocellular
7
Carcinoma
7
Urinary Bladder Neoplasms
6
Sarcoma
6
Keratosis, Actinic
6
Gastrointestinal Neoplasms
6
Endometrial Neoplasms
6
Carcinoma, Squamous Cell
6
Advanced Solid Tumors
6
Interventions
Gemcitabine
2
Oxaliplatin
1
Leucovorin
1
Irinotecan
1
Fluorouracil
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Locally Advanced Pancreatic Cancer
×
Fluorouracil
×
Clear all
NCT05466799
2026-02-13
TRIPP-FFX
OncoSil Medical Limited
Phase 2
Active not recruiting
88 enrolled